BRPI0807952A2 - Sistemas de hipermutação somática - Google Patents
Sistemas de hipermutação somáticaInfo
- Publication number
- BRPI0807952A2 BRPI0807952A2 BRPI0807952-8A2A BRPI0807952A BRPI0807952A2 BR PI0807952 A2 BRPI0807952 A2 BR PI0807952A2 BR PI0807952 A BRPI0807952 A BR PI0807952A BR PI0807952 A2 BRPI0807952 A2 BR PI0807952A2
- Authority
- BR
- Brazil
- Prior art keywords
- somatic hypermutation
- systems
- hypermutation systems
- somatic
- hypermutation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
- C40B50/06—Biochemical methods, e.g. using enzymes or whole viable microorganisms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US90241407P | 2007-02-20 | 2007-02-20 | |
| US90462207P | 2007-03-01 | 2007-03-01 | |
| US99597007P | 2007-09-28 | 2007-09-28 | |
| US2012408P | 2008-01-09 | 2008-01-09 | |
| PCT/US2008/002397 WO2008103475A1 (en) | 2007-02-20 | 2008-02-20 | Somatic hypermutation systems |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0807952A2 true BRPI0807952A2 (pt) | 2014-06-10 |
Family
ID=39710412
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0807952-8A2A BRPI0807952A2 (pt) | 2007-02-20 | 2008-02-20 | Sistemas de hipermutação somática |
Country Status (8)
| Country | Link |
|---|---|
| US (7) | US20090075378A1 (pt) |
| EP (2) | EP2126105A4 (pt) |
| JP (3) | JP2010520748A (pt) |
| AU (1) | AU2008218925A1 (pt) |
| BR (1) | BRPI0807952A2 (pt) |
| CA (1) | CA2678451A1 (pt) |
| NZ (1) | NZ579010A (pt) |
| WO (2) | WO2008103475A1 (pt) |
Families Citing this family (161)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1974017T4 (da) | 2005-12-09 | 2023-09-25 | Academisch Medisch Centrum Bij De Univ Van Amsterdam | Midler og fremgangsmåder til at påvirke stabiliteten af antistof producerende celler |
| WO2007067032A1 (en) | 2005-12-09 | 2007-06-14 | Academisch Medisch Cemtrum Bij De Universiteit Van Amsterdam | Means and methods for influencing the stability of cells |
| NZ579010A (en) | 2007-02-20 | 2012-03-30 | Anaptysbio Inc | Somatic hypermutation systems |
| JP2010538655A (ja) * | 2007-09-12 | 2010-12-16 | アナフォア インコーポレイテッド | 自己免疫疾患についてのｈｓｐ７０に基づく治療 |
| EP2098536A1 (en) | 2008-03-05 | 2009-09-09 | 4-Antibody AG | Isolation and identification of antigen- or ligand-specific binding proteins |
| WO2010042890A2 (en) | 2008-10-10 | 2010-04-15 | Anaphore, Inc. | Polypeptides that bind trail-ri and trail-r2 |
| WO2010113039A1 (en) | 2009-04-03 | 2010-10-07 | Medical Research Council | Mutants of activation-induced cytidine deaminase (aid) and methods of use |
| CN102638971B (zh) | 2009-07-08 | 2015-10-07 | 科马布有限公司 | 动物模型及治疗分子 |
| US9445581B2 (en) | 2012-03-28 | 2016-09-20 | Kymab Limited | Animal models and therapeutic molecules |
| DK2454283T3 (en) | 2009-07-15 | 2018-05-07 | Aimm Therapeutics Bv | METHODS AND PROCEDURES FOR MANUFACTURING HIGH EFFICIENCY ANTIBODIES |
| US20110082055A1 (en) * | 2009-09-18 | 2011-04-07 | Codexis, Inc. | Reduced codon mutagenesis |
| EP2478137B1 (en) * | 2009-09-18 | 2017-09-13 | Codexis, Inc. | Reduced codon mutagenesis |
| JP2013507124A (ja) * | 2009-10-09 | 2013-03-04 | アナフォア インコーポレイテッド | Ｉｌ−２３ｒを結合するポリペプチド |
| US20120251552A1 (en) * | 2009-11-05 | 2012-10-04 | Anaptysbio, Inc. | Methods of generating improved antigen-binding agents using chain shuffling and optionally somatic hypermutation |
| JP2011182645A (ja) * | 2010-03-04 | 2011-09-22 | Kyushu Univ | 動物細胞ディスプレイ法およびそれを利用した完全ヒトモノクローナル抗体の体外成熟法 |
| CN102409042B (zh) * | 2010-09-21 | 2014-05-14 | 深圳华大基因科技服务有限公司 | 一种高通量基因组甲基化dna富集方法及其所使用标签和标签接头 |
| WO2012063048A1 (en) | 2010-11-08 | 2012-05-18 | Kymab Limited | Cells & vertebrates for enhanced somatic hypermutation and class switch recombination |
| US9539324B2 (en) | 2010-12-01 | 2017-01-10 | Alderbio Holdings, Llc | Methods of preventing inflammation and treating pain using anti-NGF compositions |
| US11214610B2 (en) | 2010-12-01 | 2022-01-04 | H. Lundbeck A/S | High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as Pichia pastoris |
| US9884909B2 (en) | 2010-12-01 | 2018-02-06 | Alderbio Holdings Llc | Anti-NGF compositions and use thereof |
| US9067988B2 (en) | 2010-12-01 | 2015-06-30 | Alderbio Holdings Llc | Methods of preventing or treating pain using anti-NGF antibodies |
| NZ611076A (en) | 2010-12-01 | 2015-09-25 | Alderbio Holdings Llc | Anti-ngf compositions and use thereof |
| US9078878B2 (en) | 2010-12-01 | 2015-07-14 | Alderbio Holdings Llc | Anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75 |
| EP2647704B1 (en) | 2010-12-01 | 2017-11-01 | Mitsubishi Tanabe Pharma Corporation | Polynucleotide construct capable of presenting fab in acellular translation system, and method for manufacturing and screening fab using same |
| ES2626671T3 (es) | 2010-12-02 | 2017-07-25 | Aimm Therapeutics B.V. | Medios y métodos para producir anticuerpos de alta afinidad |
| WO2012104843A1 (en) | 2011-02-06 | 2012-08-09 | Yeda Research And Development Co.Ltd. At The Weizmann Institute Of Science | Affinity maturated t cell receptors and use thereof |
| AU2012311286B2 (en) | 2011-09-19 | 2018-07-26 | Kymab Limited | Antibodies, variable domains and chains tailored for human use |
| WO2013045916A1 (en) | 2011-09-26 | 2013-04-04 | Kymab Limited | Chimaeric surrogate light chains (slc) comprising human vpreb |
| US20130102031A1 (en) * | 2011-10-25 | 2013-04-25 | Anaptysbio, Inc. | Use of somatic hypermutation to create insertion and deletion mutations in vitro |
| US9253965B2 (en) | 2012-03-28 | 2016-02-09 | Kymab Limited | Animal models and therapeutic molecules |
| WO2013119771A1 (en) * | 2012-02-07 | 2013-08-15 | University Of Rochester | Methods of screening for activation deaminase inhibitors through nuclear import inhibitors |
| PL2814587T3 (pl) * | 2012-02-15 | 2018-10-31 | F.Hoffmann-La Roche Ag | Chromatografia powinowactwa oparta na receptorze Fc |
| US10251377B2 (en) | 2012-03-28 | 2019-04-09 | Kymab Limited | Transgenic non-human vertebrate for the expression of class-switched, fully human, antibodies |
| GB2502127A (en) * | 2012-05-17 | 2013-11-20 | Kymab Ltd | Multivalent antibodies and in vivo methods for their production |
| ES3065694T3 (en) | 2012-04-11 | 2026-05-07 | Us Health | Chimeric antigen receptors targeting b-cell maturation antigen |
| US20150377887A1 (en) * | 2013-02-27 | 2015-12-31 | Yu-Cheng Su | In situ affinity maturation of antibodies |
| CN105308457B (zh) | 2013-03-14 | 2018-07-10 | 斯坦福大学托管董事会 | 检测供体特异性抗体的方法和用于实施所述方法的系统 |
| US9788534B2 (en) | 2013-03-18 | 2017-10-17 | Kymab Limited | Animal models and therapeutic molecules |
| US9783618B2 (en) | 2013-05-01 | 2017-10-10 | Kymab Limited | Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics |
| US11707056B2 (en) | 2013-05-02 | 2023-07-25 | Kymab Limited | Animals, repertoires and methods |
| JP6742903B2 (ja) | 2013-05-02 | 2020-08-19 | アナプティスバイオ インコーポレイティッド | プログラム死−１（ｐｄ−１）に対する抗体 |
| US9783593B2 (en) | 2013-05-02 | 2017-10-10 | Kymab Limited | Antibodies, variable domains and chains tailored for human use |
| TWI707038B (zh) | 2013-08-05 | 2020-10-11 | 美商扭轉生物科技有限公司 | 重新合成之基因庫 |
| CA2925723A1 (en) | 2013-10-01 | 2015-04-09 | Kymab Limited | Animal models and therapeutic molecules |
| RU2693084C2 (ru) | 2014-01-10 | 2019-07-01 | Анаптисбайо, Инк. | Антитела, направленные против интерлейкина-33 (il-33) |
| WO2015115892A1 (en) | 2014-01-31 | 2015-08-06 | Aimm Therapeutics B.V. | Means and methods for producing stable antibodies |
| KR102328069B1 (ko) | 2014-02-21 | 2021-11-17 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 알로스테릭 단백질의 신생 설계 |
| MY186389A (en) | 2014-05-13 | 2021-07-22 | Univ Pennsylvania | Compositions comprising aav expressing dual antibody constructs and uses thereof |
| CN106536564B (zh) | 2014-06-02 | 2021-08-31 | 美国卫生和人力服务部 | 靶向cd-19的嵌合抗原受体 |
| EP3215528B1 (en) | 2014-11-06 | 2019-08-07 | F.Hoffmann-La Roche Ag | Fc-region variants with modified fcrn-binding and methods of use |
| MA41463A (fr) | 2015-02-03 | 2017-12-12 | Anaptysbio Inc | Anticorps dirigés contre le gène d'activation 3 des lymphocytes (lag-3) |
| WO2016126882A1 (en) | 2015-02-04 | 2016-08-11 | Twist Bioscience Corporation | Methods and devices for de novo oligonucleic acid assembly |
| EP3277321B1 (en) | 2015-04-01 | 2024-08-14 | AnaptysBio, Inc. | Antibodies directed against t cell immunoglobulin and mucin protein 3 (tim-3) |
| RU2745898C2 (ru) | 2015-04-15 | 2021-04-02 | Анаптисбайо, Инк. | Антитела, направленные против рецептора интерлейкина 36 (il-36r) |
| EP3283512A4 (en) * | 2015-04-17 | 2018-10-03 | Distributed Bio Inc | Method for mass humanization of non-human antibodies |
| US9981239B2 (en) | 2015-04-21 | 2018-05-29 | Twist Bioscience Corporation | Devices and methods for oligonucleic acid library synthesis |
| EA201792500A1 (ru) | 2015-05-13 | 2018-04-30 | Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания | Aav-опосредованная экспрессия антител против гриппа и способы их использования |
| KR20180050411A (ko) | 2015-09-18 | 2018-05-14 | 트위스트 바이오사이언스 코포레이션 | 올리고핵산 변이체 라이브러리 및 그의 합성 |
| CN108698012A (zh) | 2015-09-22 | 2018-10-23 | 特韦斯特生物科学公司 | 用于核酸合成的柔性基底 |
| EP3355920A4 (en) | 2015-09-29 | 2019-05-15 | Celgene Corporation | PD-1 BINDING PROTEINS AND METHOD OF USE THEREOF |
| EP3368692B1 (en) * | 2015-10-29 | 2021-07-21 | Temple University Of The Commonwealth System Of Higher Education | Modification of 3' terminal ends of nucleic acids by dna polymerase theta |
| US10527613B2 (en) * | 2015-11-10 | 2020-01-07 | The Board Of Trustees Of The Leland Stanford Junior University | Biomarker detection methods and systems and kits for practicing same |
| GB201521447D0 (en) * | 2015-12-04 | 2016-01-20 | Ucb Biopharma Sprl | De novo antibody design |
| CN118185874A (zh) * | 2016-04-04 | 2024-06-14 | 苏黎世联邦理工学院 | 一种重组哺乳动物b细胞 |
| US11401527B2 (en) | 2016-04-17 | 2022-08-02 | The Trustees Of The University Of Pennsylvania | Compositions and methods useful for prophylaxis of organophosphates |
| WO2017210149A1 (en) * | 2016-05-31 | 2017-12-07 | Igc Bio, Inc. | Compositions and methods for generating an antibody library |
| EP3468994A1 (en) | 2016-06-08 | 2019-04-17 | Intrexon Corporation | Cd33 specific chimeric antigen receptors |
| GB2553274A (en) * | 2016-07-29 | 2018-03-07 | Nuclera Nucleics Ltd | Novel use |
| WO2018035159A1 (en) | 2016-08-15 | 2018-02-22 | Enevolv, Inc. | Molecule sensor systems |
| EP3515943A4 (en) | 2016-09-19 | 2020-05-06 | Celgene Corporation | METHODS OF TREATING VITILIGO WITH PD-1 BINDING PROTEINS |
| WO2018053405A1 (en) | 2016-09-19 | 2018-03-22 | Celgene Corporation | Methods of treating immune disorders using pd-1 binding proteins |
| WO2018057526A2 (en) | 2016-09-21 | 2018-03-29 | Twist Bioscience Corporation | Nucleic acid based data storage |
| EP3666794A1 (en) | 2016-11-01 | 2020-06-17 | AnaptysBio, Inc. | Antibodies directed against programmed death- 1 (pd-1) |
| SG11201903867YA (en) | 2016-11-01 | 2019-05-30 | Anaptysbio Inc | Antibodies directed against t cell immunoglobulin and mucin protein 3 (tim-3) |
| EP3565844B8 (en) | 2017-01-09 | 2023-04-12 | Tesaro, Inc. | Methods of treating cancer with anti-pd-1 antibodies |
| JP7118073B2 (ja) | 2017-01-09 | 2022-08-15 | テサロ， インコーポレイテッド | 抗ｔｉｍ－３抗体を用いてがんを処置する方法 |
| CA3049652A1 (en) | 2017-01-10 | 2018-07-19 | Intrexon Corporation | Modulating expression of polypeptides via new gene switch expression systems |
| CN110892485B (zh) | 2017-02-22 | 2024-03-22 | 特韦斯特生物科学公司 | 基于核酸的数据存储 |
| BR112019017697A2 (pt) | 2017-02-28 | 2020-04-07 | The Trustees Of The University Of Pennsylvania | vacinas contra influenza baseadas em vetores de vírus adenoassociado (aav) |
| JOP20190200A1 (ar) | 2017-02-28 | 2019-08-27 | Univ Pennsylvania | تركيبات نافعة في معالجة ضمور العضل النخاعي |
| MX2019010275A (es) | 2017-02-28 | 2019-10-15 | Univ Pennsylvania | Novedoso vector del subtipo f del virus adenoasociado (aav) y usos de este. |
| SG11201908489XA (en) * | 2017-03-15 | 2019-10-30 | Twist Bioscience Corp | De novo synthesized combinatorial nucleic acid libraries |
| CA3063807A1 (en) | 2017-05-18 | 2018-11-22 | Umc Utrecht Holding B.V. | Compositions and methods for cell targeting therapies |
| AU2018281316B2 (en) | 2017-06-07 | 2024-05-30 | Precigen, Inc. | Expression of novel cell tags |
| JP7169999B2 (ja) | 2017-06-12 | 2022-11-11 | ツイスト バイオサイエンス コーポレーション | シームレス核酸アセンブリのための方法 |
| WO2018231864A1 (en) | 2017-06-12 | 2018-12-20 | Twist Bioscience Corporation | Methods for seamless nucleic acid assembly |
| US10174295B1 (en) * | 2017-08-01 | 2019-01-08 | The Charles Stark Draper Laboratory, Inc. | Composition of matter: engineering of Escherichia coli phage K1E |
| SG11202000499RA (en) | 2017-08-01 | 2020-02-27 | Medimmune Llc | Bcma monoclonal antibody-drug conjugate |
| AU2018328847A1 (en) | 2017-09-11 | 2020-04-23 | Twist Bioscience Corporation | GPCR binding proteins and synthesis thereof |
| TW201922280A (zh) | 2017-10-09 | 2019-06-16 | 美商安納普提斯生物公司 | 用於異位性皮膚炎之抗-il-33 療法 |
| WO2019079769A1 (en) | 2017-10-20 | 2019-04-25 | Twist Bioscience Corporation | HEATED NANOWELLS FOR THE SYNTHESIS OF POLYNUCLEOTIDES |
| EP4715681A2 (en) | 2018-01-04 | 2026-03-25 | Atlas Data Storage, Inc. | Dna-based digital information storage |
| IL277128B2 (en) | 2018-03-06 | 2025-11-01 | Precigen Inc | Hepatitis b vaccines and uses of the same |
| US12404306B2 (en) | 2018-03-06 | 2025-09-02 | Precigen, Inc. | Human papillomavirus vaccines and uses of the same |
| IL278771B2 (en) | 2018-05-18 | 2025-09-01 | Twist Bioscience Corp | Polynucleotides, reagents and methods for nucleic acid hybridization |
| WO2019219979A1 (en) | 2018-05-18 | 2019-11-21 | Umc Utrecht Holding B.V. | Compositions and methods for cell targeting therapies |
| US11155606B2 (en) | 2018-07-24 | 2021-10-26 | Medimmune, Llc | Antibody directed against S. aureus clumping factor a (ClfA) |
| TW202021983A (zh) | 2018-09-21 | 2020-06-16 | 美商安納普提斯生物公司 | 用於嗜伊紅性氣喘之抗il-33療法 |
| TW202028237A (zh) | 2018-09-27 | 2020-08-01 | 美商西建公司 | SIRPα結合蛋白及其使用方法 |
| EP3856773A1 (en) | 2018-09-28 | 2021-08-04 | Kyowa Kirin Co., Ltd. | Il-36 antibodies and uses thereof |
| BR112021006622A2 (pt) | 2018-10-09 | 2021-07-20 | Medimmune, Llc | combinações de anticorpos anti-staphylococcus aureus |
| WO2020076790A1 (en) | 2018-10-09 | 2020-04-16 | Medimmune, Llc | Antibodies directed against staphylococcus aureus leukotoxins |
| CN109325017B (zh) * | 2018-10-25 | 2022-03-04 | 中国辐射防护研究院 | 一种放射性核素迁移扩散数值模拟系统的数据库设计方法 |
| WO2020139871A1 (en) | 2018-12-26 | 2020-07-02 | Twist Bioscience Corporation | Highly accurate de novo polynucleotide synthesis |
| AU2020227802A1 (en) | 2019-02-26 | 2021-10-14 | Twist Bioscience Corporation | Variant nucleic acid libraries for antibody optimization |
| WO2020176678A1 (en) | 2019-02-26 | 2020-09-03 | Twist Bioscience Corporation | Variant nucleic acid libraries for glp1 receptor |
| US12264194B2 (en) | 2019-03-13 | 2025-04-01 | Medimmune, Llc | Decreasing Staphylococcus aureus infections in colonized patients |
| CN114096559B (zh) | 2019-03-27 | 2026-03-20 | 蒂嘉特克斯公司 | 工程化iga抗体及其使用方法 |
| WO2020210650A1 (en) | 2019-04-12 | 2020-10-15 | Medimmune, Llc | Neutralization of tgf-beta or alpha-v-beta-8 integrin for s. aureus infections |
| JP7490679B2 (ja) | 2019-06-05 | 2024-05-27 | アナプティスバイオ インコーポレイティッド | Ｐｄ－１アゴニストおよびそれを使用する方法 |
| CA3144644A1 (en) | 2019-06-21 | 2020-12-24 | Twist Bioscience Corporation | Barcode-based nucleic acid sequence assembly |
| EP4031172A4 (en) * | 2019-09-16 | 2024-02-21 | Chen, Dalu | METHOD FOR BLOCKING ASV INFECTION BY DISRUPTING CELL RECEPTORS |
| US12091777B2 (en) | 2019-09-23 | 2024-09-17 | Twist Bioscience Corporation | Variant nucleic acid libraries for CRTH2 |
| EP4034564A4 (en) | 2019-09-23 | 2023-12-13 | Twist Bioscience Corporation | VARIANT NUCLEIC ACID LIBRARIES FOR SINGLE-DOMAIN ANTIBODIES |
| CN114929747A (zh) | 2019-11-05 | 2022-08-19 | 詹森生物科技公司 | 多发性骨髓瘤的靶向bcma的car-t细胞疗法 |
| BR112022011235A2 (pt) | 2019-12-09 | 2022-12-13 | Twist Bioscience Corp | Bibliotecas de variantes de ácido nucleico para receptores de adenosina |
| WO2021186398A1 (en) | 2020-03-19 | 2021-09-23 | Medimmune Limited | Anti-klebsiella pneumoniae antibodies and uses thereof |
| WO2021247761A1 (en) * | 2020-06-02 | 2021-12-09 | University Of Southern California | Methods and compositions for in vitro affinity maturation of monoclonal antibodies |
| WO2022012680A1 (en) | 2020-07-16 | 2022-01-20 | Nanjing Legend Biotech Co., Ltd. | Cd20 binding molecules and uses thereof |
| JP2023536851A (ja) | 2020-07-30 | 2023-08-30 | アナプティスバイオ インコーポレイティッド | 魚鱗癬のための抗インターロイキン３６受容体（ｉｌ－３６ｒ）療法 |
| WO2022026829A1 (en) | 2020-07-30 | 2022-02-03 | Anaptysbio, Inc. | Anti-interleukin 36 receptor (il-36r) therapy for skin toxicity |
| WO2022031576A1 (en) | 2020-08-03 | 2022-02-10 | Janssen Biotech, Inc. | Materials and methods for multidirectional biotransportation in virotherapeutics |
| IL276599A (en) | 2020-08-09 | 2022-03-01 | Yeda Res & Dev | T cell receptor unique to mage-a1 and its uses |
| WO2022060806A1 (en) | 2020-09-16 | 2022-03-24 | Obsidian Therapeutics, Inc. | Compositions and methods for expression of anti-bcma chimeric antigen receptors with small molecule-regulated il15 in t cells |
| EP4232480A2 (en) | 2020-10-23 | 2023-08-30 | AnaptysBio, Inc. | B and t lymphocyte attenuator (btla) modulators and method of using same |
| WO2022116086A1 (en) | 2020-12-03 | 2022-06-09 | Janssen Biotech, Inc. | Bcma-targeted car-t cell therapy for multiple myeloma |
| JP2024502832A (ja) | 2020-12-31 | 2024-01-23 | アラマー バイオサイエンシーズ， インコーポレイテッド | 高親和性及び／または特異性を有する結合剤分子ならびにその製造及び使用方法 |
| WO2022150644A1 (en) | 2021-01-08 | 2022-07-14 | Anaptysbio, Inc. | Anti-interleukin 36 receptor (il-36r) therapy for acne |
| WO2022150642A1 (en) | 2021-01-08 | 2022-07-14 | Anaptysbio, Inc. | Anti-interleukin 36 receptor (il-36r) therapy for hidradenitis suppurativa |
| US20250114452A1 (en) | 2021-08-04 | 2025-04-10 | The Regents Of The University Of Colorado, A Body Corporate | Lat activating chimeric antigen receptor t cells and methods of use thereof |
| WO2023077343A1 (en) | 2021-11-04 | 2023-05-11 | Janssen Biotech, Inc. | Bcma-targeted car-t cell therapy for multiple myeloma |
| AU2022381186A1 (en) | 2021-11-04 | 2024-05-16 | Janssen Biotech, Inc. | Bcma-targeted car-t cell therapy for multiple myeloma |
| GB202117928D0 (en) | 2021-12-11 | 2022-01-26 | Cancer Research Tech Ltd | Immunotherapy for cancer |
| CN114264821B (zh) * | 2021-12-24 | 2024-04-26 | 江南大学 | 检测新型冠状病毒中和抗体的试剂盒及其制备方法与应用 |
| UY40097A (es) | 2022-01-07 | 2023-07-14 | Johnson & Johnson Entpr Innovation Inc | Materiales y métodos de proteínas de unión a il-1b |
| US20230270786A1 (en) | 2022-02-28 | 2023-08-31 | Janssen Biotech, Inc. | Bcma-targeted car-t cell therapy for multiple myeloma |
| US20250304913A1 (en) | 2022-04-06 | 2025-10-02 | The Regents Of The University Of Colorado, A Body Corporate | Chimeric antigen receptor t cells and methods of use thereof |
| WO2023196921A1 (en) | 2022-04-06 | 2023-10-12 | The Regents Of The University Of Colorado, A Body Corporate | Granzyme expressing t cells and methods of use |
| KR20250007603A (ko) | 2022-04-27 | 2025-01-14 | 아납티스바이오, 아이엔씨. | B 및 t 림프구 감쇠제(btla) 조절제 및 이를 사용하는 방법 |
| EP4554969A1 (en) | 2022-07-15 | 2025-05-21 | Janssen Biotech, Inc. | Material and methods for improved bioengineered pairing of antigen-binding variable regions |
| WO2024050457A1 (en) | 2022-08-31 | 2024-03-07 | Boost Biopharma, Inc. | Sars-cov-2 binding agents and uses thereof |
| WO2024062161A1 (en) | 2022-09-21 | 2024-03-28 | Orion Corporation | Antibody discovery and development method |
| WO2024089551A1 (en) | 2022-10-25 | 2024-05-02 | Janssen Biotech, Inc. | Msln and cd3 binding agents and methods of use thereof |
| IL320520A (en) | 2022-11-07 | 2025-06-01 | Anaptysbio Inc | CD 122 binding factors and methods of using them |
| WO2024191919A1 (en) | 2023-03-10 | 2024-09-19 | The Regents Of The University Of Colorado, A Body Corporate | Anti-cd56 and anti-cd99 logic gated chimeric antigen receptors for the treatment of cancer |
| WO2024191918A1 (en) | 2023-03-10 | 2024-09-19 | The Regents Of The University Of Colorado, A Body Corporate | Anti-cd276 and anti-cd99 logic gated chimeric antigen receptors for the treatment of cancer |
| WO2024206856A2 (en) * | 2023-03-30 | 2024-10-03 | Thomas Jefferson University | Dna-dependent synthesis of rna by dna polymerase theta variants |
| CA3205511A1 (en) | 2023-04-19 | 2025-03-17 | Janssen Biotech, Inc. | Bcma-targeted car-t cell therapy for multiple myeloma |
| WO2024243594A1 (en) | 2023-05-25 | 2024-11-28 | Anaptysbio, Inc. | Btla agonist for mudulation of dendritic cells |
| GB202309512D0 (en) | 2023-06-23 | 2023-08-09 | Astrazeneca Ab | Lilrb2 binding proteins and uses thereof |
| KR20260051068A (ko) | 2023-08-07 | 2026-04-15 | 얀센 바이오테크 인코포레이티드 | Enpp3 및 cd3 결합제 및 이의 사용 방법 |
| WO2025126102A1 (en) | 2023-12-12 | 2025-06-19 | Janssen Biotech, Inc. | Enpp3 × cd3 bispecific antibodies and use thereof |
| WO2025128434A1 (en) | 2023-12-14 | 2025-06-19 | The Regents Of The University Of Colorado, A Body Corporate | Compositions and methods for the treatment of ven/aza resistant acute myeloid leukemia |
| WO2025170902A1 (en) | 2024-02-05 | 2025-08-14 | Legend Biotech Usa Inc. | Bcma-targeted car-t cell therapy for multiple myeloma |
| US20250339527A1 (en) | 2024-03-12 | 2025-11-06 | Legend Biotech Usa Inc. | Bcma-targeted car-t cell therapy for multiple myeloma |
| WO2025231372A2 (en) | 2024-05-03 | 2025-11-06 | Janssen Biotech, Inc. | Methods for treating multiple myeloma with car-t cells and bispecific antibodies |
| US20260041768A1 (en) | 2024-05-03 | 2026-02-12 | Janssen Biotech, Inc. | Methods for treating multiple myeloma with car-t cells and bispecific antibodies |
| WO2025251015A1 (en) | 2024-05-30 | 2025-12-04 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Pan-gi norovirus monoclonal antibody and its use |
| WO2026033437A1 (en) | 2024-08-07 | 2026-02-12 | Janssen Biotech, Inc. | Methods of treating autoimmune diseases comprising the administration of anti-bcma therapeutics |
| WO2026060381A1 (en) | 2024-09-13 | 2026-03-19 | Anaptysbio, Inc. | Cd 122 binding agents for inhibiting an immune response in celiac disease or related conditions |
| WO2026090579A1 (en) | 2024-10-25 | 2026-04-30 | Janssen Biotech, Inc. | Methods of treating smoldering multiple myeloma with ciltacabtagene autoleucel |
Family Cites Families (138)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4356270A (en) * | 1977-11-08 | 1982-10-26 | Genentech, Inc. | Recombinant DNA cloning vehicle |
| US4275149A (en) * | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| US4318980A (en) | 1978-04-10 | 1982-03-09 | Miles Laboratories, Inc. | Heterogenous specific binding assay employing a cycling reactant as label |
| GB8308235D0 (en) * | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| DE3546807C2 (pt) * | 1985-03-30 | 1991-03-28 | Marc Genf/Geneve Ch Ballivet | |
| US4737456A (en) | 1985-05-09 | 1988-04-12 | Syntex (U.S.A.) Inc. | Reducing interference in ligand-receptor binding assays |
| CA1293460C (en) | 1985-10-07 | 1991-12-24 | Brian Lee Sauer | Site-specific recombination of dna in yeast |
| US5618920A (en) | 1985-11-01 | 1997-04-08 | Xoma Corporation | Modular assembly of antibody genes, antibodies prepared thereby and use |
| US5583024A (en) * | 1985-12-02 | 1996-12-10 | The Regents Of The University Of California | Recombinant expression of Coleoptera luciferase |
| GB8601597D0 (en) | 1986-01-23 | 1986-02-26 | Wilson R H | Nucleotide sequences |
| US5221623A (en) | 1986-07-22 | 1993-06-22 | Boyce Thompson Institute For Plant Research, Inc. | Use of bacterial luciferase structural genes for cloning and monitoring gene expression in microorganisms and for tagging and identification of genetically engineered organisms |
| US4937190A (en) | 1987-10-15 | 1990-06-26 | Wisconsin Alumni Research Foundation | Translation enhancer |
| US5070012A (en) | 1988-03-30 | 1991-12-03 | The Board Of Trustees Of The Leland Stanford Junior University | Monitoring of cells and trans-activating transcription elements |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US6291159B1 (en) * | 1989-05-16 | 2001-09-18 | Scripps Research Institute | Method for producing polymers having a preselected activity |
| US6291161B1 (en) * | 1989-05-16 | 2001-09-18 | Scripps Research Institute | Method for tapping the immunological repertiore |
| US6291158B1 (en) | 1989-05-16 | 2001-09-18 | Scripps Research Institute | Method for tapping the immunological repertoire |
| US6969586B1 (en) | 1989-05-16 | 2005-11-29 | Scripps Research Institute | Method for tapping the immunological repertoire |
| US6291160B1 (en) * | 1989-05-16 | 2001-09-18 | Scripps Research Institute | Method for producing polymers having a preselected activity |
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| US5683888A (en) | 1989-07-22 | 1997-11-04 | University Of Wales College Of Medicine | Modified bioluminescent proteins and their use |
| US6916605B1 (en) | 1990-07-10 | 2005-07-12 | Medical Research Council | Methods for producing members of specific binding pairs |
| US5283179A (en) * | 1990-09-10 | 1994-02-01 | Promega Corporation | Luciferase assay method |
| US5871974A (en) * | 1990-09-28 | 1999-02-16 | Ixsys Inc. | Surface expression libraries of heteromeric receptors |
| US5698426A (en) | 1990-09-28 | 1997-12-16 | Ixsys, Incorporated | Surface expression libraries of heteromeric receptors |
| US6893845B1 (en) * | 1990-09-28 | 2005-05-17 | Applied Molecular Evolution, Inc. | Surface expression libraries of heteromeric receptors |
| WO1992008796A1 (en) | 1990-11-13 | 1992-05-29 | Immunex Corporation | Bifunctional selectable fusion genes |
| WO1992015694A1 (en) * | 1991-03-08 | 1992-09-17 | The Salk Institute For Biological Studies | Flp-mediated gene modification in mammalian cells, and compositions and cells useful therefor |
| US5384261A (en) * | 1991-11-22 | 1995-01-24 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
| DE69233528T2 (de) | 1991-11-25 | 2006-03-16 | Enzon, Inc. | Verfahren zur Herstellung von multivalenten antigenbindenden Proteinen |
| PT1696031E (pt) | 1991-12-02 | 2010-06-25 | Medical Res Council | Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos |
| FR2685004A1 (fr) | 1991-12-11 | 1993-06-18 | Pasteur Institut | Procede de generation d'une diversite structurale et fonctionnelle dans une sequence peptidique. |
| WO1993022457A1 (en) | 1992-04-24 | 1993-11-11 | Massachusetts Institute Of Technology | Screening for genetic variation |
| DE614989T1 (de) * | 1993-02-17 | 1995-09-28 | Morphosys Proteinoptimierung | Verfahren für in vivo Selektion von Ligandenbindende Proteine. |
| US5770428A (en) * | 1993-02-17 | 1998-06-23 | Wisconsin Alumni Research Foundation | Chimeric retrovial expression vectors and particles containing a simple retroviral long terminal repeat, BLV or HIV coding regions and cis-acting regulatory sequences, and an RNA translational enhancer with internal ribsome entry site |
| US5855827A (en) * | 1993-04-14 | 1999-01-05 | Adroit Systems, Inc. | Pulse detonation synthesis |
| AU6953394A (en) | 1993-05-21 | 1994-12-20 | Targeted Genetics Corporation | Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene |
| US5814618A (en) | 1993-06-14 | 1998-09-29 | Basf Aktiengesellschaft | Methods for regulating gene expression |
| US5464758A (en) | 1993-06-14 | 1995-11-07 | Gossen; Manfred | Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters |
| US6027877A (en) | 1993-11-04 | 2000-02-22 | Gene Check, Inc. | Use of immobilized mismatch binding protein for detection of mutations and polymorphisms, purification of amplified DNA samples and allele identification |
| NZ281023A (en) * | 1994-01-27 | 1998-04-27 | Human Genome Sciences Inc | Human dna mismatch repair proteins and coding sequences |
| US6335160B1 (en) | 1995-02-17 | 2002-01-01 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
| JP3466765B2 (ja) | 1994-07-27 | 2003-11-17 | キッコーマン株式会社 | ビオチン化ホタルルシフェラーゼ、ビオチン化ホタルルシフェラーゼ遺伝子、新規な組み換え体ｄｎａ、ビオチン化ホタルルシフェラーゼの製造法及び生物発光分析法 |
| JP3659261B2 (ja) * | 1994-10-20 | 2005-06-15 | モルフォシス・アクチェンゲゼルシャフト | 組換体タンパク質の多機能性複合体への標的化ヘテロ結合 |
| US5741657A (en) * | 1995-03-20 | 1998-04-21 | The Regents Of The University Of California | Fluorogenic substrates for β-lactamase and methods of use |
| JPH11509735A (ja) * | 1995-07-31 | 1999-08-31 | サントル ド ルシェルシュ ド ロピタール サント ジュスティーヌ | 遺伝子導入、遺伝子治療及びタンパク質合成のための陽性選択マーカーとしてのシチジンデアミナーゼｃＤＮＡ |
| ATE219517T1 (de) * | 1995-08-18 | 2002-07-15 | Morphosys Ag | Protein-/(poly)peptidbibliotheken |
| US6696248B1 (en) * | 1995-08-18 | 2004-02-24 | Morphosys Ag | Protein/(poly)peptide libraries |
| US5843757A (en) | 1995-08-24 | 1998-12-01 | The Johns Hopkins University | Human JTV1 gene overlaps PMS2 gene |
| US6037149A (en) | 1995-08-24 | 2000-03-14 | Magainin Pharmaceuticals Inc. | DNA encoding human asthma associated factor 1 |
| US6740506B2 (en) | 1995-12-07 | 2004-05-25 | Diversa Corporation | End selection in directed evolution |
| US6713279B1 (en) * | 1995-12-07 | 2004-03-30 | Diversa Corporation | Non-stochastic generation of genetic vaccines and enzymes |
| US5885827A (en) | 1996-01-23 | 1999-03-23 | The Regents Of The Universtiy Of California | Eukaryotic high rate mutagenesis system |
| US6699658B1 (en) * | 1996-05-31 | 2004-03-02 | Board Of Trustees Of The University Of Illinois | Yeast cell surface display of proteins and uses thereof |
| US5955604A (en) * | 1996-10-15 | 1999-09-21 | The Regents Of The University Of California | Substrates for β-lactamase and uses thereof |
| JP2004510681A (ja) | 1998-02-06 | 2004-04-08 | イレクサス・ピーティーワイ・リミテッド | Ｆｃ受容体の三次元構造およびモデル並びにその使用 |
| US6146894A (en) | 1998-04-14 | 2000-11-14 | The Johns Hopkins University | Method for generating hypermutable organisms |
| WO2000015214A1 (en) | 1998-09-11 | 2000-03-23 | Ilexus Pty Limited | Fc RECEPTOR MODULATORS AND USES THEREOF |
| JP4302894B2 (ja) * | 1998-10-09 | 2009-07-29 | メディカル リサーチ カウンシル | 多様性を生み出す方法 |
| US20020155453A1 (en) * | 1998-10-09 | 2002-10-24 | Sale Julian Edward | Method for generating diversity |
| US7122339B2 (en) | 1998-10-09 | 2006-10-17 | Medical Research Council | Method for generating diversity |
| US20040038317A1 (en) * | 1999-03-15 | 2004-02-26 | Kalobios, Inc. | Breakpoint fusion fragment complementation system |
| CA2365601A1 (en) * | 1999-03-29 | 2000-10-05 | Kansai Technology Licensing Organization Co., Ltd. | Novel cytidine deaminase |
| US6855544B1 (en) * | 1999-04-15 | 2005-02-15 | Crucell Holland B.V. | Recombinant protein production in a human cell |
| DE60039510D1 (de) * | 1999-05-27 | 2008-08-28 | Us Gov Health & Human Serv | Immunokonjugate mit hoher bindungsaffinität |
| ATE482275T1 (de) | 1999-07-02 | 2010-10-15 | Morphosys Ag | Erzeugung spezifischer bindungspartner die an von genomischen dns-fragmenten oder ests kodierten (poly)peptiden binden |
| EP1282708B1 (en) * | 2000-02-18 | 2008-07-02 | Morphotek, Inc. | A method for generating hypermutable plants |
| DK1259628T5 (da) * | 2000-02-23 | 2018-06-14 | Univ Johns Hopkins | Fremgangsmåde til dannelse af hypermutabel gær |
| GB0008419D0 (en) * | 2000-04-05 | 2000-05-24 | Bioinvent Int Ab | A method for invitro molecular evolution of antibody function |
| CA2408826C (en) * | 2000-05-12 | 2012-08-14 | The Johns Hopkins University | A method for generating hypermutable organisms |
| FR2814642B1 (fr) | 2000-10-03 | 2005-07-01 | Ass Pour Le Dev De La Rech En | Souris transgenique pour la recombinaison ciblee mediee par la cre-er modifiee |
| US6808894B1 (en) * | 2000-11-07 | 2004-10-26 | Morphotek, Inc. | Methods for generating genetically altered antibody producing cell lines with improved antibody characteristics |
| US6576468B1 (en) * | 2000-11-07 | 2003-06-10 | Morphotek, Inc. | Methods for obtaining microbe-resistant mammalian cells from hypermutable mammalian cells |
| US7235643B2 (en) | 2000-11-07 | 2007-06-26 | Morphotek, Inc. | Antibodies and methods for generating genetically altered antibodies with high affinity |
| ATE423467T1 (de) | 2000-11-07 | 2009-03-15 | Morphotek Inc | Verfahren zur herstellung von genetisch modifizierten antikörperproduzierenden zelllinien mit verbesserten antikörpereigenschaften |
| US6737268B1 (en) * | 2000-11-14 | 2004-05-18 | Morphotek, Inc. | Method for generating genetically altered antigens |
| US20030096401A1 (en) * | 2000-11-28 | 2003-05-22 | Huse William D. | Eukaryotic expression libraries and methods of use |
| WO2002057423A2 (en) * | 2001-01-16 | 2002-07-25 | Regeneron Pharmaceuticals, Inc. | Isolating cells expressing secreted proteins |
| US6723433B2 (en) * | 2001-03-02 | 2004-04-20 | 3M Innovative Properties Company | Printable film and coating composition exhibiting stain resistance |
| US20050048512A1 (en) | 2001-04-26 | 2005-03-03 | Avidia Research Institute | Combinatorial libraries of monomer domains |
| JP4369662B2 (ja) * | 2001-04-26 | 2009-11-25 | アビディア インコーポレイテッド | 単量体ドメインのコンビナトリアルライブラリー |
| US20050089932A1 (en) * | 2001-04-26 | 2005-04-28 | Avidia Research Institute | Novel proteins with targeted binding |
| US20050053973A1 (en) | 2001-04-26 | 2005-03-10 | Avidia Research Institute | Novel proteins with targeted binding |
| US20040175756A1 (en) | 2001-04-26 | 2004-09-09 | Avidia Research Institute | Methods for using combinatorial libraries of monomer domains |
| EP2340849A1 (en) | 2001-05-30 | 2011-07-06 | Genentech, Inc. | Anti-NGF antibodies for the treatment of various disorders |
| US7097984B2 (en) * | 2001-07-31 | 2006-08-29 | University Of Medicine And Dentistry Of New Jersey | Method of utilizing neurotrophins to manipulate reproductive capacity |
| US7371849B2 (en) * | 2001-09-13 | 2008-05-13 | Institute For Antibodies Co., Ltd. | Methods of constructing camel antibody libraries |
| AU2002336760A1 (en) | 2001-09-26 | 2003-06-10 | Mayo Foundation For Medical Education And Research | Mutable vaccines |
| US20030119190A1 (en) | 2001-10-03 | 2003-06-26 | Wang Clifford Lee | Genetic tagging strategy for inducing and identifying mutations in a genomic sequence |
| FR2833612B1 (fr) * | 2001-12-18 | 2006-01-27 | Inst Necker | Procede pour l'induction maitrisee de mutations somatiques et son application en proteomique |
| IL162111A0 (en) * | 2001-12-22 | 2005-11-20 | 4Antibody Ag | Method for the generation of generically modified vertebrate precursor lymphocytes and use thereof for the production of heterologo |
| AU2003214842A1 (en) * | 2002-01-17 | 2003-09-02 | Albert Einstein College Of Medicine Of Yeshiva University | Mutations caused by activation-induced cytidine deaminase |
| US7335478B2 (en) * | 2002-04-18 | 2008-02-26 | Kalobios Pharmaceuticals, Inc. | Reactivation-based molecular interaction sensors |
| US7432063B2 (en) | 2002-02-14 | 2008-10-07 | Kalobios Pharmaceuticals, Inc. | Methods for affinity maturation |
| EP1572935A4 (en) | 2002-02-21 | 2006-09-13 | Morphotek Inc | PROCESS FOR THE PREPARATION OF HYPERMUTABLE CELLS USING PMSR HOMOLOGATES |
| EP1506288B1 (en) | 2002-05-10 | 2013-04-17 | Medical Research Council | Activation induced deaminase (aid) |
| CA2488441C (en) * | 2002-06-03 | 2015-01-27 | Genentech, Inc. | Synthetic antibody phage libraries |
| JP2004033137A (ja) * | 2002-07-05 | 2004-02-05 | Tasuku Honjo | 抗癌剤のスクリーニング方法 |
| JP4527531B2 (ja) * | 2002-07-19 | 2010-08-18 | モーフオテク・インコーポレーテツド | 改良された増殖の特徴を伴う高められた抗体産生細胞株の生成方法 |
| JPWO2004029713A1 (ja) * | 2002-09-30 | 2006-01-26 | 独立行政法人産業技術総合研究所 | 超短レーザーパルス発生方法及び装置 |
| CA2500901A1 (en) * | 2002-10-04 | 2004-04-22 | Rinat Neuroscience Corp. | Methods for treating cardiac arrhythmia and preventing death due to cardiac arrhythmia using ngf antagonists |
| EP1556083B1 (en) | 2002-10-08 | 2011-02-02 | Rinat Neuroscience Corp. | Methods for treating post-surgical pain by admisnistering an antibody against nerve growth factor and compositions containing the same |
| US7754450B2 (en) | 2002-11-15 | 2010-07-13 | Morphotek, Inc. | Methods of generating high-production of antibodies from hybridomas created by in vitro immunization |
| AU2002953381A0 (en) | 2002-12-18 | 2003-01-09 | Diatech Pty Ltd | In vivo affinity maturation scheme |
| EP2270048B1 (en) | 2002-12-24 | 2015-11-11 | Rinat Neuroscience Corp. | Anti-NGF antibodies and methods using same |
| US20050008625A1 (en) * | 2003-02-13 | 2005-01-13 | Kalobios, Inc. | Antibody affinity engineering by serial epitope-guided complementarity replacement |
| KR20050111598A (ko) | 2003-02-19 | 2005-11-25 | 리나트 뉴로사이언스 코퍼레이션 | 신경 성장 인자 길항제 및 ｎｓａｉｄ를 투여함으로써통증을 치료하는 방법 및 그것을 함유하는 조성물 |
| US6861422B2 (en) | 2003-02-26 | 2005-03-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions |
| US20050048578A1 (en) * | 2003-06-26 | 2005-03-03 | Epitomics, Inc. | Methods of screening for monoclonal antibodies with desirable activity |
| MEP31508A (hr) | 2003-07-15 | 2010-10-10 | Amgen Inc | Humana anti-ngf neutrališuća antitijela kao selektivni ihibitori ngf signalne kaskade |
| WO2005007121A2 (en) * | 2003-07-18 | 2005-01-27 | Massachusetts Institute Of Technology | Mutant interleukin-2(il-2) polypeptides |
| DE602004031681D1 (de) | 2003-07-21 | 2011-04-14 | Transgene Sa | Multifunktionelle Cytokine |
| US20050022686A1 (en) * | 2003-07-28 | 2005-02-03 | Dreampatch, Llc | Apparatus, method, and computer program product for animation pad transfer |
| EP1648511A1 (en) | 2003-07-29 | 2006-04-26 | Morphotek, Inc. | Antibodies and methods for generating genetically altered antibodies with enhanced effector function |
| US6957845B2 (en) * | 2003-07-31 | 2005-10-25 | Dana Corporation | Space frame cross member with integrated door seal feature |
| US20050106667A1 (en) * | 2003-08-01 | 2005-05-19 | Genentech, Inc | Binding polypeptides with restricted diversity sequences |
| US7604994B2 (en) | 2003-09-03 | 2009-10-20 | Morphotek, Inc. | Genetically altered antibody-producing cell lines with improved antibody characteristics |
| WO2005040229A2 (en) | 2003-10-24 | 2005-05-06 | Avidia, Inc. | Ldl receptor class a and egf domain monomers and multimers |
| AU2004291910A1 (en) * | 2003-11-14 | 2005-06-02 | Massachusetts Institute Of Technology | Anti-hydroxylase antibodies and uses thereof |
| WO2005056599A2 (en) | 2003-12-08 | 2005-06-23 | Morphotek, Inc. | Antibodies that specifically bind pms2 |
| JP4782700B2 (ja) | 2004-01-20 | 2011-09-28 | カロバイオス ファーマシューティカルズ インコーポレイティッド | 最低限必須な結合決定基を用いた抗体特異性の移入 |
| EP1725112A4 (en) | 2004-02-05 | 2007-10-24 | Massachusetts Inst Technology | CELL DISPLAY LIBRARIES |
| EP1716179A2 (en) | 2004-02-12 | 2006-11-02 | Morphotek, Inc. | Monoclonal antibodies that specifically bind to folate receptor alpha |
| US7767792B2 (en) | 2004-02-20 | 2010-08-03 | Ludwig Institute For Cancer Research Ltd. | Antibodies to EGF receptor epitope peptides |
| EP1568765A1 (en) * | 2004-02-23 | 2005-08-31 | GSF-Forschungszentrum für Umwelt und Gesundheit GmbH | Method for genetic diversification in gene conversion active cells |
| AU2005243247B2 (en) | 2004-04-07 | 2012-03-01 | Regents Of The University Of Minnesota | Methods for treating bone cancer pain by administering a nerve growth factor antagonist |
| US7785903B2 (en) | 2004-04-09 | 2010-08-31 | Genentech, Inc. | Variable domain library and uses |
| US11674240B2 (en) * | 2004-07-06 | 2023-06-13 | Pfizer Inc. | Universal antibody libraries |
| US20060080745A1 (en) | 2004-10-08 | 2006-04-13 | Cornell Research Foundation, Inc. | Gene reactivation by somatic hypermutation |
| US7393923B2 (en) * | 2004-11-08 | 2008-07-01 | The Regents Of The University Of California | Red-shifted fluorescent proteins mPlum and mRaspberry and polynucleotides encoding the same |
| EP2343380B1 (en) | 2004-11-16 | 2019-06-12 | Humanigen, Inc. | Immunoglobulin variable region cassette exchange |
| EP1869192B1 (en) * | 2005-03-18 | 2016-01-20 | MedImmune, LLC | Framework-shuffling of antibodies |
| EP1943332A4 (en) * | 2005-10-14 | 2011-04-13 | Medimmune Inc | CELLULAR DISPLAY OF ANTIBODY LIBRARIES |
| NZ579010A (en) | 2007-02-20 | 2012-03-30 | Anaptysbio Inc | Somatic hypermutation systems |
-
2008
- 2008-02-20 NZ NZ579010A patent/NZ579010A/en unknown
- 2008-02-20 AU AU2008218925A patent/AU2008218925A1/en not_active Abandoned
- 2008-02-20 EP EP08725985A patent/EP2126105A4/en not_active Withdrawn
- 2008-02-20 US US12/070,905 patent/US20090075378A1/en not_active Abandoned
- 2008-02-20 CA CA002678451A patent/CA2678451A1/en not_active Abandoned
- 2008-02-20 JP JP2009550936A patent/JP2010520748A/ja active Pending
- 2008-02-20 WO PCT/US2008/002397 patent/WO2008103475A1/en not_active Ceased
- 2008-02-20 WO PCT/US2008/002396 patent/WO2008103474A1/en not_active Ceased
- 2008-02-20 US US12/070,904 patent/US8603950B2/en active Active
- 2008-02-20 BR BRPI0807952-8A2A patent/BRPI0807952A2/pt not_active Application Discontinuation
- 2008-02-20 EP EP08725984A patent/EP2126087A4/en not_active Ceased
- 2008-02-20 JP JP2009550935A patent/JP5675109B2/ja active Active
-
2010
- 2010-12-17 US US12/972,328 patent/US20110183855A1/en not_active Abandoned
-
2011
- 2011-05-17 US US13/109,106 patent/US8685897B2/en active Active
- 2011-10-12 US US13/272,065 patent/US20120028301A1/en not_active Abandoned
-
2013
- 2013-04-26 JP JP2013094218A patent/JP2013220103A/ja active Pending
- 2013-10-11 US US14/052,451 patent/US9637556B2/en active Active
-
2014
- 2014-02-14 US US14/181,096 patent/US9260533B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20110183855A1 (en) | 2011-07-28 |
| JP2013220103A (ja) | 2013-10-28 |
| WO2008103475A1 (en) | 2008-08-28 |
| EP2126105A4 (en) | 2010-11-03 |
| EP2126105A1 (en) | 2009-12-02 |
| US20090075378A1 (en) | 2009-03-19 |
| US8603950B2 (en) | 2013-12-10 |
| US20140170705A1 (en) | 2014-06-19 |
| JP5675109B2 (ja) | 2015-02-25 |
| JP2010520748A (ja) | 2010-06-17 |
| AU2008218925A1 (en) | 2008-08-28 |
| EP2126087A1 (en) | 2009-12-02 |
| US20140094392A1 (en) | 2014-04-03 |
| US8685897B2 (en) | 2014-04-01 |
| US20110287485A1 (en) | 2011-11-24 |
| JP2010518859A (ja) | 2010-06-03 |
| EP2126087A4 (en) | 2010-10-27 |
| US9637556B2 (en) | 2017-05-02 |
| CA2678451A1 (en) | 2008-08-28 |
| US20090093024A1 (en) | 2009-04-09 |
| NZ579010A (en) | 2012-03-30 |
| US20120028301A1 (en) | 2012-02-02 |
| WO2008103474A1 (en) | 2008-08-28 |
| US9260533B2 (en) | 2016-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2126105A4 (en) | SOMATIC HYPERPERMUTATION SYSTEMS | |
| ATE481948T1 (de) | Linseneinführsystem | |
| BRPI0821019A2 (pt) | Sistema de comunicação | |
| ATE427720T1 (de) | Linseneinfuhrsystem | |
| FI20060131A0 (fi) | Yhteysjärjestelmä | |
| ATE431117T1 (de) | Linseneinführsystem | |
| DK2118055T3 (da) | Antiparasitmidler | |
| FI20075368L (fi) | Oksasakset | |
| EP2146804A4 (en) | COATING SYSTEM | |
| EP2227553A4 (en) | Lac expression system | |
| CR9342S (es) | Regadera | |
| DE602007009224D1 (de) | R-cellular-systemen | |
| DK1955639T3 (da) | Rengøringssystem | |
| EP2187651A4 (en) | NETWORK SYSTEM | |
| FI20075972A0 (fi) | Tietoliikennejärjestelmä | |
| IT1398018B1 (it) | Obice rimorchiato | |
| EP2211736C0 (en) | EMBRYONIC CONTROL SYSTEM | |
| NL2002066A1 (nl) | Trailer. | |
| DK2205488T3 (da) | Sprøjteanlæg | |
| NL1035129A1 (nl) | Verlichtingssysteem. | |
| SE0701400L (sv) | Odlingssystem | |
| AT506162A3 (de) | Ablaufanlage | |
| SE0701319L (sv) | Ventilationssystem | |
| ES1066323Y (es) | Estaca de cultivo | |
| FI7844U1 (fi) | Yhteysjärjestelmä |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |